Plus   Neg

MarineMax Q4 Profit Rises

MarineMax Inc. (HZO) reported that its net income for the fourth-quarter ended September 30, 2018, was $11.5 million or $0.50 per share, compared to net income of $3.9 million, or $0.17 per diluted share in the comparable period last year.

Excluding the impact from the gain in 2018 and the unusual items in 2017, adjusted earnings per share for the quarter ended September 30, 2018 increased 105% to $0.45, compared with adjusted diluted earnings per share for the same period last year.

For the quarter ended September 30, 2018, revenue increased over 23% to $309 million from $251 million for the comparable quarter last year. Same-store sales for the quarter grew 22%, on top of 5% growth for the comparable period last year.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.23 per share and revenues of $273.31 million for the quarter. Analysts' estimates typically exclude special items.

The company currently expects fully taxed earnings per share to be in the range of $1.85 to $1.95 for fiscal 2019. This compared to a non-GAAP adjusted diluted earnings per share of $1.70 in fiscal 2018. Analysts expect annual earnings of $1.68 per share.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT